Sustained granulocyte recovery after G-CSF in a patient with ticlopidine-induced severe aplastic anemia
1995; Wiley; Volume: 50; Issue: 4 Linguagem: Inglês
10.1002/ajh.2830500419
ISSN1096-8652
AutoresKarmele Arribalzaga, Julio García‐Suárez, Marina López‐Rubio, Isabel Krsnik, M. A. Calero, Juan Francisco Del Campo,
Tópico(s)Acute Lymphoblastic Leukemia research
ResumoAmerican Journal of HematologyVolume 50, Issue 4 p. 313-313 Letters and CorrespondenceFree Access Sustained granulocyte recovery after G-CSF in a patient with ticlopidine-induced severe aplastic anemia K. Arribalzaga, K. Arribalzaga Servicio de Hematología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorJ. García-Suárez, J. García-Suárez Servicio de Hematología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorM. López-Rubio, M. López-Rubio Servicio de Hematología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorI. Krsnik, I. Krsnik Servicio de Hematología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorM. A. Calero, M. A. Calero Servicio de Hematología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorJ. F. Del Campo, J. F. Del Campo Servicio de Hematología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, SpainSearch for more papers by this author K. Arribalzaga, K. Arribalzaga Servicio de Hematología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorJ. García-Suárez, J. García-Suárez Servicio de Hematología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorM. López-Rubio, M. López-Rubio Servicio de Hematología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorI. Krsnik, I. Krsnik Servicio de Hematología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorM. A. Calero, M. A. Calero Servicio de Hematología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorJ. F. Del Campo, J. F. Del Campo Servicio de Hematología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, SpainSearch for more papers by this author First published: December 1995 https://doi.org/10.1002/ajh.2830500419Citations: 3AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 Goyan JE: Ticlopidine: Quo vadis? Adverse reaction in man. Agent Action 15(suppl): 16, 1984. 2 Martin-Núñez G Ramos R, Sánchez-Gil F, Benitez-Cano E: Aplastic anaemia and Ticlopidine. Br J Haematol 85: 633– 640, 1993. 3 Elias M Reichman N, Flatau E: Bone marrow aplasia associated with ticlopidine therapy. Am J Hematol 44: 289– 291, 1993. 4 Lieschke GJ, Burgess AW: Granulocyte colony-stimulating factor and granulocytemacrophage colony-stimulating factor (second of two parts). N Engl J Med 327: 99– 106, 1992. 5 Ono K Kurohara K Yoshihara M Shimamoto Y, Yamaguchi M: Agranulocytosis caused by Ticlopidine and its mechanism. Am J Hematol 37: 239– 242, 1991. Citing Literature Volume50, Issue4December 1995Pages 313-313 ReferencesRelatedInformation
Referência(s)